Stomach Neoplasm
1 competing product in clinical development for Stomach Neoplasm.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| EO-3021 + Ramucirumab (CYRAMZA®) + Dostarlimab | CSPC Pharmaceutical Group Limited | Phase 1 | Terminated | 32 |